Birth Control Pills Breast Cancer
First over-the-counter birth control pill gets FDA approval in US
US officials have approved the first over-the-counter birth control pill, which will let American women and girls buy contraceptive medication from the same aisle as aspirin and eyedrops. The Food and Drug Administration said Thursday it cleared Perrigo's once-a-day Opill to be sold without a prescription, making it the first such medication to be moved out from behind the pharmacy counter. The company won't start shipping the pill until early next year, and there will be no age restrictions on sales. Hormone-based pills have long been the most common form of birth control in the US, used by tens of millions of women since the 1960s. Until now, all of them required a prescription. Medical societies and women's health groups have pushed for wider access, noting that an estimated 45% of the 6 million annual pregnancies in the US are unintended. Teens and girls, women of colour and those with low incomes report greater hurdles in getting prescriptions and picking them up. Some of the
 "First over-the-counter birth control pill gets FDA approval in US")
Birth control pills may up breast cancer risk: Research
Researchers from the University of Copenhagen in Denmark said the risk of breast cancer was higher among women who recently used contemporary hormonal contraceptives
 "Birth control pills may up breast cancer risk: Research")
